MORGAN STANLEY: High-flying tech stocks are headed for a rude awakening. Here's how top executives are making the situation even worse.

Morgan Stanley equity strategists highlight several signs that tech-sector sentiment has gotten overextended, and they put some blame on management.

April 03, 2019   |   View Online »

MORGAN STANLEY: High-flying tech stocks are headed for a rude awakening. Here's how top executives are making the situation even worse. Joe Ciolli | Morgan Stanley equity strategists highlight several signs that tech-sector sentiment has gotten overextended, and they put some blame on management. Read More »

BANK OF AMERICA: The stocks outshining the market's powerful rally are poised for a sharp reversal — but there's a way to avoid the losses ahead Akin Oyedele | Bank of America's analysts provide a trading recommendation to profit from a negative turnaround in some of the market's best-performing stocks. Read More »

Nomura is reportedly slashing more than 100 jobs this week, but insiders are bracing for a bigger shock Trista Kelley,Callum Burroughs | Job cuts are coming at Nomura. While staff in the struggling international unit are expecting a brutal announcement, they still may be in for a shock. Read More »

Pharma giant Bayer is making a bet that one day we might be able to use stem cells to prevent cancer Lydia Ramsey | Bayer's investment arm, Leaps by Bayer, is investing in Khloris, a company looking to use stem-cell-based vaccines to prevent and treat cancer. Read More »

Barclays senior executive Art Mbanefo is leaving the bank following a major shakeup Trista Kelley | Mbanefo was the deputy to Tim Throsby, who left Barclays last week. Read More »

These 19 former Facebook employees are now leading some of the hottest enterprise tech startups Rosalie Chan and Rob Price | Many of the tools quietly underpinning the modern internet are built by Facebook alumni. Here are the key faces you need to know. Read More »

A $23 billion drugmaker and a $2 billion biotech upstart are racing to develop a type of 'silver bullet' drug for aggressive cancers that has eluded their industry for 30 years Emma Court | If these experimental products are successful, they could rake in billions in sales and help patients with few treatment options. Read More »

California marijuana company Vertical is talking to banks about an IPO for its CBD business and just raised a fresh $58 million in preparation Jeremy Berke | Vertical President Smoke Wallin said he's aiming to list the CBD spinoff on the NASDAQ by the fourth quarter of this year. Read More »

Morgan Stanley's recession dashboard is flashing a signal it's never shown before — and the firm has put together a game plan to avoid the losses to come Akin Oyedele | The firm's strategists say a cycle peak is "imminent" and it's time to turn defensive. Read More »

This former Google Analytics exec just came out of stealth mode with a new Accel-backed startup that tracks how workers use their apps Rosalie Chan | Here's how former Google Analytics Premium head Jody Shapiro launched Productiv out of stealth with an $8 million investment led by Accel. Read More »

Share This Email    Read Business Insider On The Go

Email sent to: nguyenvu1187.love5@blogger.com Manage your email preferences   |   Unsubscribe Terms of Service   |   Privacy Policy Business Insider. 150 Fifth Ave, New York, NY 10011